Clinical Trial Update: A Randomized, Placebo-controlled, Tourette Syndrome Study. [Phase 3]

View source ↗

Summary

A Phase 3 randomized, placebo-controlled trial in Tourette Syndrome has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Snippet

Sponsor: Baylor College of Medicine | Conditions: Tourette Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2017-11-06